logo

For the Inventor, By the Inventor

Milan, Italy

Alberto Bianchetti

This inventor holds 19 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Pharmacia & Upjohn, Elf Sanofi. Active years: 1977-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Bianchetti. Retrieved from https://idiyas.com/inventor/alberto-bianchetti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 128(Granted Patents)


Company Filing History:

goldMedal9 out of 1,549 
 
Sanofi
 patents
silverMedal4 out of 117 
 
Pharmacia & Upjohn
 patents
bronzeMedal3 out of 53 
 
Elf Sanofi
 patents
4. 3 out of 2,029 
 
University System of Maryland
 patents
5. 2 out of 25 
 
Pierrel Spa
 patents
6. 1 out of 220 
 
Pharmacia Corporation
 patents
where one patent can have more than one assignee

Years Active: 1977-2001

Loading Chart...
Areas of Expertise:
Kynurenines
Anxiety Treatment
Depression
Trifluoromethyl
Phenylethanolamine
Amidobenzamides
Indolyl Acetic Acid
Anorectic Agents
Benzazepine Compounds
Fluoro-substituted
Amino Acids
Peripheral Opiate Antagonists
19 patents (USPTO):Explore Patents
1. 6207709 - N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds having kynurenine-3-hydroxy base inhibitory activity (2001-03-27),
2. 5973006 - Fluoro-substituted benzoylpropionic acid derivatives (1999-10-26),
3. 5786508 - Substituted kynurenines and process for their preparation (1998-07-28),
4. 5708030 - Substituted kynurenines and process for their preparation (1998-01-13),
5. 5604245 - Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a (1997-02-18),
6. 5519055 - Substituted kynurenines and process for their preparation (1996-05-21),
7. 5270341 - Method of treatment or prophylaxis of depression and stress (1993-12-14),
8. 5266573 - Trifluoromethylphenyltetrahydropyridines for the treatment and/or (1993-11-30),
9. 5109005 - Trifluoromethylphenyltetrahydropyridines for the treatment and/or (1992-04-28),
10. 5026716 - Method of treatment of anxiety and anxio-depressive disorders (1991-06-25),
11. 5002946 - Phenylethanolamine analog active compounds for the treatment of (1991-03-26),
12. 4735947 - Methyllevallorphanium salts having peripheral opiate antagonistic (1988-04-05),
13. 4707497 - Phenylethanolaminotetralines, a process for their preparation and (1987-11-17),
14. 4691019 - Anorectic agent; (1987-09-01),
15. 4602024 - Substituted trifluoromethylphenyltetrahydropyridines having a cyano (1986-07-22),

Title: **Alberto Bianchetti: Innovator in Pharmaceutical Chemistry**

Introduction

Alberto Bianchetti is a prominent inventor based in Milan, Italy, making significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 19 patents, his work primarily focuses on innovative compounds with therapeutic potential.

Latest Patents

Among his latest patents, Bianchetti developed compounds such as the N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid, known for its kynurenine-3-hydroxy base inhibitory activity. Another notable invention includes fluoro-substituted benzoylpropionic acid derivatives, showcasing his dedication to advancing medicinal chemistry through unique chemical compositions.

Career Highlights

Throughout his career, Alberto Bianchetti has made invaluable contributions while working with leading pharmaceutical companies such as Sanofi and Pharmacia & Upjohn S.p.a. His expertise and innovative spirit have established him as a key figure in drug development and discovery.

Collaborations

Bianchetti has collaborated with distinguished professionals in the industry, including Tiziano Croci and Dino Nisato. These partnerships have enriched his research efforts and expanded the impact of his inventions within the scientific community.

Conclusion

Alberto Bianchetti’s contributions to the field of pharmaceutical chemistry are marked by a series of patents that reflect his innovative approach. His work not only advances medical science but also inspires future inventors in the quest for new therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…